Trans Chromosomics Inc.
PrivateLast Round
Grant
Jun 30, 2025
Total Funding Raised
$872,888
Company Overview
Trans Chromosomics Inc. is a biotechnology company that provides a drug discovery platform utilizing chromosome engineering technology, including the development of human antibody-producing animals and models for evaluating drug efficacy and toxicity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trans Chromosomics Inc. Comparables
Compare Trans Chromosomics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Harbour BioMed | 78% | |
| Cyagen Biosciences | 78% | |
| Biocytogen | 77% | |
Trans Chromosomics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 30, 2025 | ||||
| Grant | Sep 25, 2024 | ||||
| Grant | Jul 22, 2023 | ||||
| VC Round | Jun 27, 2019 | ||||
| VC Round | Jul 27, 2018 | ||||
VC Round | Jan 25, 2017 |
Trans Chromosomics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TNP Threads of Light | VC Round |
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Tottori Capital | VC Round |
| North Carolina Department of Commerce | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2025
$75K grant from North Carolina Department of Commerce.
- Oct 29, 2024
Monthly visitors increased 33% MoM.
Trans Chromosomics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Trans Chromosomics Inc.'s valuation, stock price, and market status.